PRO DEX vs Tela Bio
PRO DEX and Tela Bio are similar in size: $77.5m and $80.3m of revenue in their latest fiscal years. PRO DEX grew faster (16.5% against 15.8%). PRO DEX kept more of each dollar of sales as profit: a net margin of 17.6% against -48.4%. PRO DEX carries less debt relative to equity (45.6% against 881.6%).
| Latest fiscal year | PRO DEXPDEX, 2026 | Tela BioTELA, 2025 |
|---|---|---|
| Revenue | $77.5m | $80.3m |
| Revenue growth | 16.5% | 15.8% |
| Net income | $13.7m | −$38.8m |
| Operating margin | 16.8% | -42.0% |
| Net margin | 17.6% | -48.4% |
| Return on equity | 32.4% | — |
| Free cash flow | $6.8m | −$28.7m |
| Cash | $8.2m | $50.8m |
| Total debt | $21.7m | $55.7m |
| Debt to equity | 45.6% | 881.6% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | $3.4m | — |
| Employees | 206 | 150 |
| Market value | $192m | $35.2m |
| Price vs our value range | Above our value range | — |
| Moat score | 70 (Strong) | 34 (Weak) |
| Insider trades, 12 months | 0 buys, 20 sales | 7 buys, 0 sales |